Parkinson’s Institute and Clinical Center Company Profile

12:45 EDT 24th April 2018 | BioPortfolio

The Parkinson’s Institute and Clinical Center is at the forefront of patient care and therapy development. We are the nation’s only Institute that provides patient care, basic science research, and clinical research in one integrated model. Our unique freestanding organization directly connects research to patient care – from the “bench to bedside.” For 30 years, our team of epidemiologists, physicians, scientists, and therapists, have been at the forefront of every clinical and scientific discovery in the field of Parkinson’s research.

News Articles [2550 Associated News Articles listed on BioPortfolio]

Parkinson’s Institute and Clinical Center Collaborates With Denali Therapeutics to Explore New Endpoints for Clinical Studies

The Parkinson’s Institute and Clinical Center and Denali Therapeutics today announced a partnership to explore new clinical endpoints for studies in patients with Parkinson’s ...

India Globalization Capital Partners with Parkinson’s Institute and Clinical Center to Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorders (PDMD)

BETHESDA, Md., March 01, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) today announces that it has signed a Joint Development and Services Agreement with the pres...

Parkinson’s Institute and Clinical Center Collaborates with Merck to Evaluate LRRK2 Kinase Inhibition in Preclinical Model of Parkinson’s Disease

The Parkinson’s Institute and Clinical Center has entered into a collaboration with Merck, known as MSD outside the United States and Canada, to study the effects of LRRK2 kinas...

[Comment] Hypercholinergic activity in LRRK2 Parkinson's disease

Mutations of the LRRK2 gene are a common cause of autosomal-dominant Parkinson's disease. The clinical features of manifest LRRK2 Parkinson's disease are generally indistinguishable from those of spor...

Fox Insight’s Observational Clinical Study Offers Hope For Parkinson’s Disease Cures

Clinical Informatics News | The Michael J. Fox Foundation for Parkinson’s Research is using patient reported outcomes to find a cure for Parkinson’s Disease with Fox Insight, a “patient-pow...

The Michael J. Fox Foundation Launches Parkinson’s Clinical Trial Platform

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) launched an educational suite dubbed the “Parkinson’s Clinical Trial Companion.”

Parkinson's disease: A looming pandemic

(University of Rochester Medical Center) New research shows that the number of people with Parkinson's disease will soon grow to pandemic proportions. In a commentary appearing today in the journal J...

PAIRing up in Parkinson’s

Insights from Parkinson’s advocates led Pfizer to simplify its clinical program and measure outcomes more important to patients.

Drugs and Medications [402 Associated Drugs and Medications listed on BioPortfolio]

Exelon [Novartis Pharmaceuticals Corporation]

These highlights do not include all the information needed to use Exelon  Patch safely and effectively. See full prescribing information for Exelon Patch.       Exelon  Patch (rivastig

Aprodine [Rebel Distributors Corp]


Premier value chest congestion and cough releif [Reese Pharmaceutical Co]

drug facts

Care one chest congestion relief [Reese Pharmaceutical Co]

drug facts

Cvs chest congestion relief [Reese Pharmaceutical Co]

Drug Facts CVS Congestion Relief DM

PubMed Articles [3351 Associated PubMed Articles listed on BioPortfolio]

Diabetes mellitus and Parkinson disease.

To investigate whether diabetes mellitus is associated with Parkinson-like pathology in people without Parkinson disease and to evaluate the effect of diabetes mellitus on markers of Parkinson patholo...

Diminished EEG habituation to novel events effectively classifies Parkinson's patients.

We aimed to test if EEG responses to novel events reliably dissociated individuals with Parkinson's disease and controls, and if this dissociation was sensitive and specific enough to be a candidate b...

Pallidal low β-low γ phase-amplitude coupling inversely correlates with Parkinson disease symptoms.

Recent discoveries suggest that it is most likely the coupling of β oscillations (13-30Hz) and not merely their power that relates to Parkinson disease (PD) pathophysiology.

App-Based Bradykinesia Tasks for Clinic and Home Assessment in Parkinson's Disease: Reliability and Responsiveness.

Clinical rating of bradykinesia in Parkinson disease (PD) is challenging as it must combine several movement features into a single score. Additionally, in-clinic assessment cannot capture fluctuation...

Clinical Research Nursing: Development of a Residency Program

Clinical research nurses are essential in the coordination of clinical trials and the management of research participants. Without a stable, knowledgeable research nurse workforce, the conduct of rese...

Clinical Trials [4994 Associated Clinical Trials listed on BioPortfolio]

The Clinical Profile of Parkinson Disease in Egypt

Multi-center, retrospective observational cohort study in 4 tertiary referral centers in Cairo over the period from 2004 to 2016. Study population. including all patients with idiopathic ...

Phase 2, Double-Blind, Randomized, Controlled Multi-Center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.

The purpose of this study was to evaluate the differences in safety and efficacy between Parkinson's disease patients who either received transplantation of fetal porcine cells or placebo ...

Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression

This is a observational, multi-center study to assess progression of clinical features, imaging and biologic biomarkers in Parkinson disease (PD) patients compared to healthy controls (HC)...

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

Study participants who have been clinically diagnosed with Parkinson disease will receive no treatment, treatment with either levodopa, or treatment with Mirapex for a period of 12 weeks. ...

Twins and the Risk of Parkinson's Disease: A Clinical and Imaging Study

The purpose of this study is to examine the role of genetic and environmental factors in the cause of Parkinson's disease.

Companies [4115 Associated Companies listed on BioPortfolio]

Parkinson’s Institute and Clinical Center

The Parkinson’s Institute and Clinical Center is at the forefront of patient care and therapy development. We are the nation’s only Institute that provides patient care,...

Amarantus Therapeutics, Inc.

Amarantus Therapeutics, Inc. is a privately-held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death,...

Burnham Institute

The Burnham Institute is an independent, nonprofit, public benefit organization dedicated to basic biomedical research. Founded in 1976, the Institute was originally known as La Jolla Cancer Research ...

The Parkinson Alliance

The Parkinson Alliance is the umbrella organization for the Parkinson's Unity Walk. The Kingston, NJ-based national non-profit organization is dedicated to raising funds to help finance the most promi...

Miami Cancer Institute

Miami Cancer Institute offers comprehensive cancer services and is expanding its clinical services, clinical trials and state-of-the-art technology, including offering the first p...

More Information about "Parkinson’s Institute and Clinical Center" on BioPortfolio

We have published hundreds of Parkinson’s Institute and Clinical Center news stories on BioPortfolio along with dozens of Parkinson’s Institute and Clinical Center Clinical Trials and PubMed Articles about Parkinson’s Institute and Clinical Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Parkinson’s Institute and Clinical Center Companies in our database. You can also find out about relevant Parkinson’s Institute and Clinical Center Drugs and Medications on this site too.

Quick Search


Relevant Topic

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Corporate Database Quicklinks

Searches Linking to this Company Record